Amiel Gross is Head of Legal at the Center for Breakthrough Medicines. His responsibilities include overseeing and managing the legal function at a rapidly growing biotechnology company in cell and gene therapy manufacturing, as well as ensuring that its business strategies are aligned with all legal implications, obligations, and risks. Gross offers legal services to clients in the biotechnology industry. They specialize in complex commercial transactions, strategic alliances and counseling executives and senior management. The company's professional oversight responsibility and hands-on experience includes a range of subject matters, including licensing deals, master services agreements, procurement contracts, intellectual property, corporate affairs, sponsored R&D collaborations, FDA regulatory and compliance, litigation and labor and employment. Amiel Gross is a professional who has studied International Law at the Queen Mary University of London. Amiel holds a Bachelor of Arts Degree from the Southwestern University and a Doctor of Law Degree from The University of Texas School of Law.
Show moreReceive notification when a new event is posted that matches your criteria.
Mon, Sep 30, 2024
Teatro Albéniz, Calle de la Paz, Madrid, Spain
Wed, Feb 28, 2024
Online
Thu, May 23, 2024
Johannesburg, South Africa
Fri, May 17, 2024
Sky 100 Observation Deck, Austin Road West, Tsim Sha Tsui, Hong Kong
Wed, Jun 26, 2024
Berlin, Germany
Tue, May 21, 2024
Eurostars, Berlin, Germany
Please select at least one qualified/retail country